Chien‐Wei Su

8.4k total citations
229 papers, 6.0k citations indexed

About

Chien‐Wei Su is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Chien‐Wei Su has authored 229 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Hepatology, 169 papers in Epidemiology and 44 papers in Surgery. Recurrent topics in Chien‐Wei Su's work include Liver Disease Diagnosis and Treatment (146 papers), Hepatocellular Carcinoma Treatment and Prognosis (115 papers) and Hepatitis B Virus Studies (70 papers). Chien‐Wei Su is often cited by papers focused on Liver Disease Diagnosis and Treatment (146 papers), Hepatocellular Carcinoma Treatment and Prognosis (115 papers) and Hepatitis B Virus Studies (70 papers). Chien‐Wei Su collaborates with scholars based in Taiwan, United States and United Kingdom. Chien‐Wei Su's co-authors include Yi‐Hsiang Huang, Teh‐Ia Huo, Han‐Chieh Lin, Jaw‐Ching Wu, Jaw‐Ching Wu, Cheng‐Yuan Hsia, Shou‐Dong Lee, Chia‐Yang Hsu, Yi‐You Chiou and Fa‐Yauh Lee and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Chien‐Wei Su

216 papers receiving 5.9k citations

Peers

Countries citing papers authored by Chien‐Wei Su

Since Specialization

Citations

This map shows the geographic impact of Chien‐Wei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Wei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Wei Su more than expected).

Fields of papers citing papers by Chien‐Wei Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Wei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Wei Su. The network helps show where Chien‐Wei Su may publish in the future.

Co-authorship network of co-authors of Chien‐Wei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Wei Su. A scholar is included among the top collaborators of Chien‐Wei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Wei Su. Chien‐Wei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Triglyceride-glucose index and cancer risk: a prospective cohort study in Taiwan 2025 ·Diabetology & Metabolic Syndrome ·(unknown), (unknown), Chih-Jen Huang, Shiao‐Ya Hong, Hwai‐I Yang, Ying‐Ying Yang, Chia‐Chang Huang, (unknown), Tzu‐Hao Li, Chien‐Wei Su, Ming‐Chih Hou	1
2	Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade 2023 ·Cancers ·(unknown), Shu‐Yein Ho, Po‐Hong Liu, (unknown), Yi‐Hsiang Huang, Chien‐Wei Su, Ming‐Chih Hou, Teh‐Ia Huo	7
3	Entecavir versus tenofovir on prognosis of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy 2023 ·Alimentary Pharmacology & Therapeutics ·Wei‐Yu Kao, Elise Chia‐Hui Tan, Hsin‐Lun Lee, Yi‐Hsiang Huang, Teh‐Ia Huo, Chun‐Chao Chang, Jeng‐Fong Chiou, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su	8
4	The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels 2022 ·Journal of the Formosan Medical Association ·(unknown), (unknown), Chi‐Jen Chu, Pei‐Chang Lee, Teh‐Ia Huo, Yi‐Hsiang Huang, Yee Chao, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su	8
5	Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade 2022 ·International Journal of Clinical Oncology ·(unknown), Shu‐Yein Ho, Po‐Hong Liu, (unknown), Cheng‐Yuan Hsia, Yi‐Hsiang Huang, Chien‐Wei Su, (unknown), Rheun‐Chuan Lee, Ming‐Chih Hou, Teh‐Ia Huo	6
6	Efficacy of a Decision Support Intervention on Decisional Conflict Related to Hepatocellular Cancer Treatment: A Randomized Controlled Trial 2022 ·Clinical Nursing Research ·(unknown), Tsae‐Jyy Wang, Chien‐Wei Su, Shu‐Yuan Liang, Chieh‐Yu Liu, Jun‐Yu Fan	1
7	Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score 2022 ·Cancers ·Shu‐Yein Ho, Po‐Hong Liu, (unknown), Yi‐Hsiang Huang, (unknown), Chien‐Wei Su, Ming‐Chih Hou, Teh‐Ia Huo	6
8	Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection 2021 ·Cancers ·(unknown), I‐Cheng Lee, Rheun‐Chuan Lee, Ya‐Wen Hung, Chien‐Wei Su, Ming‐Chih Hou, Yee Chao, Yi‐Hsiang Huang	9
9	Easy albumin–bilirubin score as a new prognostic predictor in hepatocellular carcinoma 2021 ·Hepatology Research ·Shu‐Yein Ho, Po‐Hong Liu, Chia‐Yang Hsu, (unknown), Yi‐Hsiang Huang, Chien‐Wei Su, Cheng‐Yuan Hsia, Ping‐Hsing Tsai, Shih‐Jie Chou, Rheun‐Chuan Lee, Ming‐Chih Hou, Teh‐Ia Huo	16
10	Albumin–Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 2020 ·Digestive Diseases and Sciences ·Shu‐Yein Ho, Chia‐Yang Hsu, Po‐Hong Liu, Rheun‐Chuan Lee, (unknown), Yi‐Hsiang Huang, Chien‐Wei Su, Ming-Chih Hou, Teh‐Ia Huo	13
11	Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma 2020 ·Liver International ·Po‐Hong Liu, Chia‐Yang Hsu, Chien‐Wei Su, Yi‐Hsiang Huang, Ming‐Chih Hou, Nicole E. Rich, Naoto Fujiwara, Yujin Hoshida, Amit G. Singal, Teh‐Ia Huo	31
12	Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade 2020 ·Cancers ·Shu‐Yein Ho, Chia‐Yang Hsu, Po‐Hong Liu, (unknown), Yi‐Hsiang Huang, Chien‐Wei Su, Rheun‐Chuan Lee, Ming-Chih Hou, Teh‐Ia Huo	10
13	Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation 2020 ·Scientific Reports ·(unknown), Yi‐You Chiou, Nai‐Chi Chiu, (unknown), Chien-An Liu, Wei‐Yu Kao, Teh‐Ia Huo, Yi‐Hsiang Huang, Ming-Chih Hou, Han‐Chieh Lin, Jaw‐Ching Wu, Chien‐Wei Su	10
14	A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma 2019 ·Liver International ·I‐Cheng Lee, Ya‐Wen Hung, Chien‐An Liu, Rheun‐Chuan Lee, Chien‐Wei Su, Teh‐Ia Huo, Chung‐Pin Li, Yee Chao, Han‐Chieh Lin, Ming‐Chih Hou, Yi‐Hsiang Huang	76
15	A New Prognostic Model Based on Albumin–Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria 2019 ·Digestive Diseases and Sciences ·Shu‐Yein Ho, Po‐Hong Liu, Chia‐Yang Hsu, Cheng‐Yuan Hsia, Yi‐Hsiang Huang, Chien‐Wei Su, Hao-Jan Lei, Rheun‐Chuan Lee, Ming-Chih Hou, Teh‐Ia Huo	11
16	Albumin‐bilirubin grade‐based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma 2019 ·Liver International ·Shu‐Yein Ho, (unknown), Po‐Hong Liu, Cheng‐Yuan Hsia, (unknown), Yi‐Hsiang Huang, (unknown), Chien‐Wei Su, Rheun‐Chuan Lee, Ming‐Chih Hou, Teh‐Ia Huo	24
17	Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation 2018 ·Scientific Reports ·Shu‐Yein Ho, Po‐Hong Liu, Chia‐Yang Hsu, Yi‐You Chiou, Chien‐Wei Su, Yun-Hsuan Lee, Yi‐Hsiang Huang, Fa‐Yauh Lee, Ming-Chih Hou, Teh‐Ia Huo	27
18	Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection 2018 ·Scientific Reports ·Shu‐Yein Ho, Po‐Hong Liu, Chia‐Yang Hsu, Cheng‐Yuan Hsia, Chien‐Wei Su, Yun-Hsuan Lee, Yi‐Hsiang Huang, Fa‐Yauh Lee, Ming-Chih Hou, Teh‐Ia Huo	32
19	Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C 2018 ·Hepatology ·Wei‐Yu Kao, Chien‐Wei Su, Elise Chia‐Hui Tan, Pei‐Chang Lee, Ping‐Hsien Chen, Jui‐Hsiang Tang, Yi‐Hsiang Huang, Teh‐Ia Huo, Chun‐Chao Chang, Ming‐Chih Hou, Han‐Chieh Lin, Jaw‐Ching Wu	24
20	Validation of the albumin‐bilirubin grade‐based integrated model as a predictor for sorafenib‐failed hepatocellular carcinoma 2017 ·Liver International ·Pei‐Chang Lee, (unknown), Yee Chao, Teh‐Ia Huo, Chung‐Pin Li, Chien‐Wei Su, Mei‐Hsuan Lee, Ming‐Chih Hou, Fa‐Yauh Lee, Han‐Chieh Lin, Yi‐Hsiang Huang	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact